Borealis Biosciences

Vancouver, Canada

Borealis Biosciences is a company in the field of next-generation RNA medicines.

$30.0M raised

Dec 2024

Series A

Biotechnology Life Science Medical

Top Investors

NovartisVersant VenturesWestlake Village BioPartners

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Borealis Biosciences

How much funding has Borealis Biosciences raised?

Borealis Biosciences has raised $30.0M in total funding. The most recent round was Series A. The last funding was announced in December 2024.

Who are Borealis Biosciences's investors?

Borealis Biosciences's investors include Novartis, Versant Ventures, Westlake Village BioPartners.

Where is Borealis Biosciences headquartered?

Borealis Biosciences is headquartered in Vancouver, Canada.

What does Borealis Biosciences do?

Borealis Biosciences is a company in the field of next-generation RNA medicines.

What stage is Borealis Biosciences at?

Borealis Biosciences is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 19, 2024.

MLA

"Borealis Biosciences — Funding & Investors." VCBacked, December 19, 2024, https://www.vcbacked.co/company/borealis-biosciences. Accessed June 4, 2026.

APA

VCBacked. (2024). Borealis Biosciences — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/borealis-biosciences

Wikipedia (cite web)

{{cite web |title=Borealis Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/borealis-biosciences |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 19, 2024.